Rutgers School of Dental Medicine, New Jersey, USA.
Evid Based Dent. 2020 Dec;21(4):130-131. doi: 10.1038/s41432-020-0135-1.
Data sources The authors searched Medline via PubMed, Scopus, Web of Science, the Cochrane Library and ClinicalTrials.gov for published and unpublished clinical trials. Only randomised clinical trials, with either a parallel or crossover design, reporting the tooth sensitivity of participants undergoing in-office dental bleaching and comparing pain frequency and severity with oral premedication of a non-steroidal or other anti-inflammatory drug compared with a placebo were used in the review. Studies that evaluated the topical administration of drugs or desensitising agents were not reviewed.Study selection In total,5,050 randomised clinical studies were screened and 11 studies were included in the various meta-analyses. Nine studies examined the effect of pre-emptive analgesics on the risk of sensitivity and ten studies evaluated the effect of drugs on the severity of sensitivity; seven of these studies were assessed as having a low risk of bias.Data extraction and synthesis This systematic review and meta-analysis was conducted a priori and registered at the International Prospective Register of Systematic Reviews. There were two reviewers who extracted data from the study tables and independently performed quality assessments of the selected trials using the Office of Health Assessment and Translation risk of bias rating tool for human and animal studies. Risk ratios were calculated for the dichotomous sensitivity risk data and mean difference for measures of sensitivity intensity.Results The authors found no effect of the drugs on the risk of sensitivity. Using a visual analogue scale, the authors identified a small but clinically insignificant reduction in the level of sensitivity in the drug-treated group evaluated up to one hour after bleaching. This was not observed when a numerical rating scale was used to measure pain intensity. For the 24-hour pain data, the authors did not find any significant intensity difference between groups. Mean pain intensity scores were generally low in both experimental groups in all randomised controlled trials reviewed. Based on a visual inspection of the funnel plots of all outcomes, the authors concluded that there was no publication bias.Conclusions The data did not support the pre-emptive use of anti-inflammatory drugs in preventing or reducing the intensity of pain caused by in-office tooth bleaching.
作者通过 Medline(通过 PubMed)、Scopus、Web of Science、Cochrane 图书馆和 ClinicalTrials.gov 搜索了已发表和未发表的临床试验,仅纳入了采用平行或交叉设计、报告接受诊室牙齿漂白术的患者的牙齿敏感程度、并比较了使用非甾体抗炎药或其他抗炎药进行口腔预治疗与安慰剂相比的疼痛频率和严重程度的随机临床试验。本综述未纳入评估药物或脱敏剂局部给药的研究。
共筛选了 5050 项随机临床研究,11 项研究纳入了各种荟萃分析。9 项研究评估了预防性镇痛药对敏感性风险的影响,10 项研究评估了药物对敏感性严重程度的影响;其中 7 项研究被评估为低偏倚风险。
本系统评价和荟萃分析是事先进行的,并在国际前瞻性系统评价注册库中进行了注册。有两名评审员从研究表格中提取数据,并使用卫生评估和翻译办公室的风险偏倚评估工具(针对人类和动物研究)对选定试验进行独立的质量评估。对敏感性风险数据进行二分类,对敏感性强度进行均值差异计算,得出风险比。
作者未发现药物对敏感性风险有影响。使用视觉模拟量表,作者发现漂白后 1 小时内,药物治疗组的敏感性水平略有下降,但临床意义不大。当使用数字评分量表测量疼痛强度时,未观察到这种情况。对于 24 小时疼痛数据,作者未发现组间有任何显著的强度差异。在所有纳入的随机对照试验中,药物治疗组和安慰剂组的平均疼痛强度评分通常较低。根据所有结局的漏斗图的目视检查,作者得出结论,没有发表偏倚。
数据不支持预防性使用抗炎药来预防或减轻诊室牙齿漂白引起的疼痛强度。